Pseudohypoaldosteronism: evaluation of type I receptors by radioreceptor assay and by antireceptor antibodies.
We have previously demonstrated a deficiency of mineralocorticoid receptors in pseudohypoaldosteronism, by radioreceptorassay. We now report findings with an antireceptor antibody derived from the immunogenic region of the receptor. Lymphocytes from normal controls and from two cases of pseudohypoaldosteronism previously shown to lack receptor binding were tested. After the plasma membrane of lymphocytes was permeabilized with methanol the cells were incubated with a 1:200 dilution of antibody followed by fluorescent antirabbit immunoglobulin mouse serum. After washing fluorescence was detected by microscopy and cytofluorimetry in both controls and patients with pseudohypoaldosteronism. Recent studies on mineralocorticoid receptor cDNA in pseudohypoaldosteronism have not established a mutation in the sequence. We thus suggest that the pathogenesis of pseudohypoaldosteronism is not related to an abnormality of the receptor but rather due to intracellular factor(s) which can block the binding of aldosterone to its receptor.
Armanini
D
D
Laboratorio Analisi, Ospedale Piove di Sacco, Padua Italy.
Karbowiak
I
I
Zennaro
C M
CM
Zovato
S
S
Pratesi
C
C
De Lazzari
P
P
Krozowski
Z
Z
Kuhnle
U
U
D000328:Adult; D000906:Antibodies / Q000097:blood; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D011546:Pseudohypoaldosteronism / Q000378:metabolism*; D011869:Radioligand Assay; D018161:Receptors, Mineralocorticoid / Q000032:analysis* / Q000276:immunology
D000906:Antibodies; D018161:Receptors, Mineralocorticoid